I was interested in Kalenn's inputs/EBITDA calculations and consequent share price predictions based on the MC/EBITDA factor of 6. This spreadsheet output makes his calculations clearer for anyone that was also interested.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress